Back
Day Range
$75.71
$81.29
52-Week Range
$19.45
$103.00
Volume
923,929
50D / 200D Avg
$79.67
/
$61.62
Prev Close
$74.42
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -20.7 | 0.2 |
| P/B | 4.1 | 3.0 |
| ROE % | -25.8 | 3.6 |
| Net Margin % | -794.4 | 3.8 |
| Rev Growth 5Y % | -14.4 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$117.31
+48.6%
Low: $90.00
High: $138.00
Forward EPS
-$3.66
Est. Revenue
39.61M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
-$3.41
-$9.67 – $0.66
|
222.18M | 12 |
| FY2029 |
-$4.31
-$12.21 – $0.84
|
54.14M | 8 |
| FY2028 |
-$4.10
-$4.99 – -$3.09
|
43.17M | 14 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-26 | -$0.78 | -$0.97 | -23.8% |
| 2025-11-04 | -$0.71 | -$0.90 | -26.8% |
| 2025-08-11 | -$0.83 | -$0.95 | -14.5% |
| 2025-05-09 | -$0.92 | -$0.82 | +10.9% |
| 2025-02-27 | -$0.76 | -$0.88 | -15.8% |
| 2024-10-31 | -$0.83 | -$0.82 | +1.2% |
| 2024-08-07 | -$0.69 | -$0.58 | +15.9% |
| 2024-05-02 | -$0.73 | -$0.69 | +5.5% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue declined -14.35% annually over 5 years
Debt/Equity of 0.05 — conservative balance sheet
Negative free cash flow of -234.34M
Capital efficient — spends only 3.70% of revenue on capex
Growth
Revenue Growth (5Y)
-14.35%
Revenue (1Y)-16.72%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-25.79%
ROIC-15.77%
Net Margin-794.39%
Op. Margin-891.33%
Safety
Debt / Equity
0.05
Current Ratio10.47
Interest Coverage-1403.21
Valuation
P/E Ratio
-20.69
Forward P/EN/A
P/B Ratio4.08
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -16.72% | Revenue Growth (3Y) | -29.38% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -14.35% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 39.20M | Net Income (TTM) | -311.40M |
| ROE | -25.79% | ROA | -17.87% |
| Gross Margin | 100.00% | Operating Margin | -891.33% |
| Net Margin | -794.39% | Free Cash Flow (TTM) | -234.34M |
| ROIC | -15.77% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.05 | Current Ratio | 10.47 |
| Interest Coverage | -1403.21 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -20.69 | Forward P/E | N/A |
| P/B Ratio | 4.08 | P/S Ratio | 164.39 |
| PEG Ratio | -0.89 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 162.68 | Fwd Earnings Yield | N/A |
| FCF Yield | -3.64% | ||
| Market Cap | 6.44B | Enterprise Value | 6.17B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 39.20M | 47.07M | 78.59M | 46.83M | 72.83M |
| Net Income | -311.40M | -223.86M | -146.96M | -154.81M | -100.22M |
| EPS (Diluted) | -3.69 | -2.98 | -2.52 | -2.87 | -2.09 |
| Gross Profit | 39.20M | 47.07M | 78.59M | 46.83M | 72.83M |
| Operating Income | -349.40M | -261.64M | -165.53M | -161.26M | -100.53M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.74B | 978.04M | 575.76M | 603.13M | 605.91M |
| Total Liabilities | 163.15M | 142.42M | 180.79M | 112.98M | 146.27M |
| Shareholders' Equity | 1.58B | 835.62M | 394.97M | 490.15M | 459.64M |
| Total Debt | 82.25M | 87.76M | 84.67M | 17.34M | 17.96M |
| Cash & Equivalents | 357.01M | 120.26M | 109.97M | 68.40M | 47.98M |
| Current Assets | 871.21M | 510.27M | 405.32M | 419.42M | 451.27M |
| Current Liabilities | 83.21M | 67.77M | 85.69M | 71.34M | 92.54M |